4:30 Determining BBB Penetration & CNS Biodistribution with Enhanced PKPD Modelling Capabilities
Time: 4:30 pm
day: Day One PM
Details:
• Highlighting recent advancements in the development of PKPD efficacy models
• Studying delivery efficiency, target engagement and bioavailability of MDM2
inhibitors and radio-chemo sensitizers in the CNS
• Enhancing knowledge of their pharmacokinetic and pharmacodynamic
properties
